rs1218169616
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BP4
The NM_152709.5(STOX1):c.226C>A(p.Pro76Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152709.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000275 AC: 16AN: 58078Hom.: 0 Cov.: 8
GnomAD4 exome AF: 0.0000237 AC: 4AN: 168850Hom.: 0 Cov.: 4 AF XY: 0.0000246 AC XY: 2AN XY: 81180
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.000275 AC: 16AN: 58078Hom.: 0 Cov.: 8 AF XY: 0.000419 AC XY: 12AN XY: 28644
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.226C>A (p.P76T) alteration is located in exon 1 (coding exon 1) of the STOX1 gene. This alteration results from a C to A substitution at nucleotide position 226, causing the proline (P) at amino acid position 76 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at